No clear advantage of dual antiplatelet therapy over aspirin alone in stable patients with high cardiovascular risk: Commentary

Stephen D Persell*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)253-254
Number of pages2
JournalJournal of Clinical Outcomes Management
Issue number5
StatePublished - May 1 2006

ASJC Scopus subject areas

  • General Medicine
  • Strategy and Management

Cite this